Medtronic revenue and financials

MDT · NYSE · USD

$87.09Change from previous close: −1.00%Absolute change: −$0.88

Close · October 6, 2026

In the fiscal year ended April 2026, Medtronic reported revenue of $36.36B (+8.43% year over year). Net income was $4.8B, a net margin of 13.2%.

Annual revenue · 2026: $36.36B
  1. $29.71B2017
  2. $29.95B2018
  3. $30.56B2019
  4. $28.91B2020
  5. $30.12B2021
  6. $31.69B2022
  7. $31.23B2023
  8. $32.36B2024
  9. $33.54B2025
  10. $36.36B2026

Fiscal year ending in April. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+8.43%
FY to Apr 2026 vs FY to Apr 2025
Net income growth
+2.98%
FY to Apr 2026 vs FY to Apr 2025
Net margin
13.2%
FY to Apr 2025: 13.9%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Annual
ItemFY to Apr 2026FY to Apr 2025FY to Apr 2024FY to Apr 2023FY to Apr 2022FY to Apr 2021FY to Apr 2020FY to Apr 2019FY to Apr 2018FY to Apr 2017
Total assets93,02891,68089,98190,94890,98193,08390,68989,69491,39399,857
Current assets24,78723,81421,93521,67523,05922,54822,03121,96722,98024,873
Cash and equivalents1,9492,2181,2841,5433,7143,5934,1404,3933,6694,967
Short-term investments7,2716,7476,7216,4166,859—————
Receivables6,6436,5156,1285,9987,650—————
Inventory5,9515,4765,2175,2934,616—————
Net property, plant and equipment8,6147,9377,1436,6106,267—————
Goodwill42,58741,73740,98641,42540,50241,96139,84139,95939,54338,515
Other intangible assets10,14611,66713,22514,84415,595—————
Long-term investments8589841,3151,640915—————
Current liabilities11,65812,87910,7899,05112,3948,50910,3668,47210,08414,264
Accounts payable2,6442,4492,4102,6622,276—————
Long-term debt26,17325,64223,93224,34420,37226,37822,14024,55223,69225,874
Total liabilities42,95643,42439,56139,28338,26041,48139,81739,48240,57149,527
Total equity (incl. minority)50,07248,25650,42051,66552,722—————
Retained earnings32,63831,47630,40330,39216,849—————
Minority interest609232206182171—————